4 Trademark Results found for "FREELINE*"

Also try searching for:

FREE*

*INE

FR*NE

Details	Status	Class/Description
FREELINE DESIGN FREELINE THERAPEUTICS LIMITED 1931210 19 Nov 2018	REGISTERED on 8 Feb 2023	Pharmaceutical, medical and veterinary preparations for prevention, am... Class 005 Class 005 Pharmaceutical Products Pharmaceutical, medical and veterinary preparations for prevention, amelioration and treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious diseases; pharmaceutical, medical and clinical preparations for therapeutic and prophylactic purposes in connection with blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, agerelated macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain- Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious diseases; pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of genetic and inherited and non-infectious diseases and disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders and cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration and prophylaxis of chronic and systemic disease, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders and cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration and prophylaxis of blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS); pharmaceutical, medical and clinical preparations for use in gene therapy; pharmaceutical, medical and clinical preparations for liver-targeted viral gene therapy; genetic medicines, namely chemicals, compounds and compositions used to cure, halt and prevent genetic-based disease and illness and to ease symptoms and to help in the diagnosis of geneticbased diseases and illnesses, by modifying gene expression to correct and compensate for an abnormal phenotype, namely for use for prevention, amelioration and treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, agerelated macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain- Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS) , ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious disease; gene therapy preparations; preparations for therapeutic delivery of nucleic acids; viral and nucleic acid vector preparations, namely gene-based biological preparations and medical reagents for use in gene delivery, gene transfer, gene regulation and gene modulation for therapeutic, prophylactic and medical purposes; adeno-associated viral gene therapy preparations. Class 040 Class 040 Treatment & Processing of Materials Services Pharmaceutical manufacturing and processing to the order and specification of others; biotechnological and biopharmaceutical manufacturing and processing to the order and specification of others; viral vector production to the order and specification of others; gene therapy manufacturing to the order and specification of others; pharmaceutical formulation to the order and specification of others. ... Class 042 Computer & Software Services & Scientific Services Scientific and technological services, namely, pharmaceutical research and development; biological, medical, preclinical and clinical research and development; genetic engineering, gene editing, namely, the modification of genetic material in a living organism; genetic medicine, gene therapy and genome editing research, development, analytics, clinical trials and consultancy relating thereto; biochemical assay development and performance; diagnostics development and performance, namely development and performance of diagnostics for screening for eligibility for gene therapy and genetic medicine and assessing the efficacy of gene therapy and genetic medicine; biomarker identification, namely, detection and measurement of biological properties and molecules in the body; manufacturing analytics and manufacturing process design, development and optimisation, namely design, scale-up and optimisation of processes for manufacturing gene therapies and genetic medicines and design and development of analytics for assessing the performance characteristics of such processes; hosting a website communicating educational information relating to gene therapy and genetic medicine. Class 044 Medical, Beauty & Agricultural Services Medical services and medical analysis services in the field of genetic medicine, inherited diseases, noninfectious diseases and disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch- Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, and urological disorders, and cancers; medical services in the field of gene therapy and genetic medicine; medical services in the field of gene therapy for blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory and immune system disorders, hepatological disorders, and nervous system disorders; medical services in the field of gene and nucleic acid delivery and modification for therapeutic purposes; gene therapy design and delivery; advisory services relating to gene therapy.
FREELINE FREELINE THERAPEUTICS LIMITED 1931194 19 Nov 2018	REGISTERED on 8 Feb 2023	Pharmaceutical, medical and veterinary preparations for prevention, am... Class 005 Class 005 Pharmaceutical Products Pharmaceutical, medical and veterinary preparations for prevention, amelioration and treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious diseases; pharmaceutical, medical and clinical preparations for therapeutic and prophylactic purposes in connection with blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, agerelated macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain- Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious diseases; pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of genetic and inherited and non-infectious diseases and disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders and cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration and prophylaxis of chronic and systemic disease, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders and cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration and prophylaxis of blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS); pharmaceutical, medical and clinical preparations for use in gene therapy; pharmaceutical, medical and clinical preparations for liver-targeted viral gene therapy; genetic medicines, namely chemicals, compounds and compositions used to cure, halt and prevent genetic-based disease and illness and to ease symptoms and to help in the diagnosis of genetic-based diseases and illnesses, by modifying gene expression to correct and compensate for an abnormal phenotype, namely for use for prevention, amelioration and treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS) , ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious disease; gene therapy preparations; preparations for therapeutic delivery of nucleic acids; viral and nucleic acid vector preparations, namely gene-based biological preparations and medical reagents for use in gene delivery, gene transfer, gene regulation and gene modulation for therapeutic, prophylactic and medical purposes; adeno-associated viral gene therapy preparations. Class 040 Class 040 Treatment & Processing of Materials Services Pharmaceutical manufacturing and processing to the order and specification of others; biotechnological and biopharmaceutical manufacturing and processing to the order and specification of others; viral vector production to the order and specification of others; gene therapy manufacturing to the order and specification of others; pharmaceutical formulation to the order and specification of others. ... Class 042 Computer & Software Services & Scientific Services Scientific and technological services, namely, pharmaceutical research and development; biological, medical, preclinical and clinical research and development; genetic engineering, gene editing, namely, the modification of genetic material in a living organism; genetic medicine, gene therapy and genome editing research, development, analytics, clinical trials and consultancy relating thereto; biochemical assay development and performance; diagnostics development and performance, namely development and performance of diagnostics for screening for eligibility for gene therapy and genetic medicine and assessing the efficacy of gene therapy and genetic medicine; biomarker identification, namely, detection and measurement of biological properties and molecules in the body; manufacturing analytics and manufacturing process design, development and optimisation, namely design, scale-up and optimisation of processes for manufacturing gene therapies and genetic medicines and design and development of analytics for assessing the performance characteristics of such processes; hosting a website communicating educational information relating to gene therapy and genetic medicine. Class 044 Medical, Beauty & Agricultural Services Medical services and medical analysis services in the field of genetic medicine, inherited diseases, noninfectious diseases and disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch- Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, and urological disorders, and cancers; medical services in the field of gene therapy and genetic medicine; medical services in the field of gene therapy for blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory and immune system disorders, hepatological disorders, and nervous system disorders; medical services in the field of gene and nucleic acid delivery and modification for therapeutic purposes; gene therapy design and delivery; advisory services relating to gene therapy.
FREELINE DENIM CAVEAU DES JEANS LLTEE 1259982 6 Jun 2005	EXPUNGED on 3 Feb 2022	Vêtements nommément des jeans, pantalons, vestes, vestons, blouses, ch... Class 025 Class 025 Clothing Products Vêtements nommément des jeans, pantalons, vestes, vestons, blouses, chandails, t-shirts, ceintures, robes, salopettes, cravates, culottes courtes, chemises, jupes, short surf. Class 035 Class 035 Advertising, Business & Retail Services Vente au détail des vêtements suivants: vêtements nommément des jeans, pantalons, vestes, vestons, blouses, chandails, t-shirts, ceintures, robes, salopettes, cravates, culottes courtes, chemises, jupes, short surf.
FREELINE LECTRA SYSTEMES SOCIÉTÉ ANONYME 713831 30 Sept 1992	EXPUNGED	Installation et réparation de machines et machines outils, et installa... Class 007 Class 007 Machinery Products Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products ... Class 020 Furniture Products Machines-outils, découpeurs laser, découpeurs jet d'eau, découpeurs à couteaux, découpeurs pour pièces de patrons, matelasseurs, convoyeurs, machines d'assemblage, machines à coudre pour l'emploi dans l'industrie seulement, machines d'emballage et d'expédition; ordinateurs, micro-ordinateurs, programmes et logiciels, stations de travail informatiques, stations graphiques, moniteurs, digitaliseurs, traceurs, modules de commande électroniques pour le pilotage de machines à commande numérique, bases de données, et stylos électroniques. Class 037 Construction and Repair Services Installation et réparation de machines et machines outils, et installation et réparation d'appareils et instruments électroniques et informatiques.

REGISTERED

on 8 Feb 2023

FREELINE DESIGN

FREELINE THERAPEUTICS LIMITED

1931210 · 19 Nov 2018

005

Class 005

Pharmaceutical Products

Pharmaceutical, medical and veterinary preparations for prevention, amelioration and treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious diseases; pharmaceutical, medical and clinical preparations for therapeutic and prophylactic purposes in connection with blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, agerelated macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain- Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious diseases; pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of genetic and inherited and non-infectious diseases and disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders and cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration and prophylaxis of chronic and systemic disease, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders and cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration and prophylaxis of blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS); pharmaceutical, medical and clinical preparations for use in gene therapy; pharmaceutical, medical and clinical preparations for liver-targeted viral gene therapy; genetic medicines, namely chemicals, compounds and compositions used to cure, halt and prevent genetic-based disease and illness and to ease symptoms and to help in the diagnosis of geneticbased diseases and illnesses, by modifying gene expression to correct and compensate for an abnormal phenotype, namely for use for prevention, amelioration and treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, agerelated macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain- Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS) , ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious disease; gene therapy preparations; preparations for therapeutic delivery of nucleic acids; viral and nucleic acid vector preparations, namely gene-based biological preparations and medical reagents for use in gene delivery, gene transfer, gene regulation and gene modulation for therapeutic, prophylactic and medical purposes; adeno-associated viral gene therapy preparations.

040

...

Class 042

Computer & Software Services & Scientific Services

Scientific and technological services, namely, pharmaceutical research and development; biological, medical, preclinical and clinical research and development; genetic engineering, gene editing, namely, the modification of genetic material in a living organism; genetic medicine, gene therapy and genome editing research, development, analytics, clinical trials and consultancy relating thereto; biochemical assay development and performance; diagnostics development and performance, namely development and performance of diagnostics for screening for eligibility for gene therapy and genetic medicine and assessing the efficacy of gene therapy and genetic medicine; biomarker identification, namely, detection and measurement of biological properties and molecules in the body; manufacturing analytics and manufacturing process design, development and optimisation, namely design, scale-up and optimisation of processes for manufacturing gene therapies and genetic medicines and design and development of analytics for assessing the performance characteristics of such processes; hosting a website communicating educational information relating to gene therapy and genetic medicine.

Class 044

Medical, Beauty & Agricultural Services

Medical services and medical analysis services in the field of genetic medicine, inherited diseases, noninfectious diseases and disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch- Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, and urological disorders, and cancers; medical services in the field of gene therapy and genetic medicine; medical services in the field of gene therapy for blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory and immune system disorders, hepatological disorders, and nervous system disorders; medical services in the field of gene and nucleic acid delivery and modification for therapeutic purposes; gene therapy design and delivery; advisory services relating to gene therapy.

Pharmaceutical, medical and veterinary preparations for prevention, am...

REGISTERED

on 8 Feb 2023

FREELINE

FREELINE THERAPEUTICS LIMITED

1931194 · 19 Nov 2018

005

Class 005

Pharmaceutical Products

Pharmaceutical, medical and veterinary preparations for prevention, amelioration and treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious diseases; pharmaceutical, medical and clinical preparations for therapeutic and prophylactic purposes in connection with blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, agerelated macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain- Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious diseases; pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of genetic and inherited and non-infectious diseases and disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders and cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration and prophylaxis of chronic and systemic disease, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders and cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration and prophylaxis of blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS); pharmaceutical, medical and clinical preparations for use in gene therapy; pharmaceutical, medical and clinical preparations for liver-targeted viral gene therapy; genetic medicines, namely chemicals, compounds and compositions used to cure, halt and prevent genetic-based disease and illness and to ease symptoms and to help in the diagnosis of genetic-based diseases and illnesses, by modifying gene expression to correct and compensate for an abnormal phenotype, namely for use for prevention, amelioration and treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, namely diabetes, Hurler syndrome, Niemann-Pick disease, Tay-Sachs disease, Gaucher disease, Fabry disease, Krabbe disease, Phenylketonuria, Friedreich ataxia, Zellweger syndrome, Adrenoleukodystrophy, Wilson disease and Hemochromatosis, inflammatory disorders, namely C3 glomerulopathy, IgA nephropathy, lupus nephritis, systemic lupus erythematosus, membranous nephropathy, membranoproliferative glomerulonephritis, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, autoimmune haemolytic anemia, ANCA-associated vasculitis, peritonitis, age-related macular degeneration, diabetic retinopathy, dense deposit disease, autoimmune arthritis, rheumatoid arthritis, atherosclerosis, chronic cardiovascular disease, Alzheimer's disease, systemic vasculitis, Guillain-Barre syndrome, and Henoch-Schonlein purpura and immune system disorders, autoimmune disorders, hepatological disorders, peripheral nervous system disorders and central nervous system disorders, namely diseases of the brain, diseases of the spinal cord, Gaucher disease type 2, Gaucher disease type 3, neurodegenerative diseases namely dementia, Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS) , ocular and ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular and vascular disorders, endocrine disorders, gastrointestinal disorders, dermatological disorders and diseases namely, dermatitis, eczema and psoriasis, acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, respiratory disorders, urological disorders, cancers and infectious disease; gene therapy preparations; preparations for therapeutic delivery of nucleic acids; viral and nucleic acid vector preparations, namely gene-based biological preparations and medical reagents for use in gene delivery, gene transfer, gene regulation and gene modulation for therapeutic, prophylactic and medical purposes; adeno-associated viral gene therapy preparations.

040

...

Class 042

Computer & Software Services & Scientific Services

Class 044

Medical, Beauty & Agricultural Services

Pharmaceutical, medical and veterinary preparations for prevention, am...

EXPUNGED

on 3 Feb 2022

FREELINE DENIM

CAVEAU DES JEANS LLTEE

1259982 · 6 Jun 2005

025

035

Vêtements nommément des jeans, pantalons, vestes, vestons, blouses, ch...

EXPUNGED

FREELINE

LECTRA SYSTEMES SOCIÉTÉ ANONYME

713831 · 30 Sept 1992

007

009

...

Installation et réparation de machines et machines outils, et installa...

Owners

Freeline therapeutics limited (2)

Caveau des jeans lltee (1)

Lectra systemes société anonyme (1)